Follicular thyroid cancer

Also known as: 갑상선 여포암 갑상샘여포암

Doctors who treat Follicular thyroid cancer

See all
Samsung Seoul Hospital Son Yeong-ik

Son Yeong-ik

Samsung Seoul Hospital · Otorhinolaryngology

후두암, 갑상선암, 음성질환, 두경부암수술

5.0
Samsung Seoul Hospital Kim Jeong-han

Kim Jeong-han

Samsung Seoul Hospital · Endocrine Surgery

갑상선암, 갑상선양성종양, 부갑상선의종양, 부신종양, 악성흑색종, 경부암

4.8
Eunpyeong St. Mary's Hospital, Catholic University of Korea Bang Ju-in

Bang Ju-in

Eunpyeong St. Mary's Hospital, Catholic University of Korea · Otorhinolaryngology

갑상선암,두경부암,침샘질환(타액선내시경), 음성질환 ,성대결절, 두경부 낭종질환(초음파에탄올주입술), 편도 및 아데노이드(성인,소아)

5.0
Samsung Seoul Hospital Jung Jae-hun

Jung Jae-hun

Samsung Seoul Hospital · Endocrinology and Metabolism

갑상선질환

5.0
Samsung Seoul Hospital Kim Ji-su

Kim Ji-su

Samsung Seoul Hospital · Endocrine Surgery

갑상선암, 부갑상선의종양, 갑상선양성종양, 경부암, 갑상선의종양

5.0
Ulsan University Hospital Han Myeong-wol

Han Myeong-wol

Ulsan University Hospital · Otorhinolaryngology

갑상선암, 갑상선 로봇수술, 두경부암, 음성장애

5.0
Ewha Womans University Mokdong Hospital Kim Han-su

Kim Han-su

Ewha Womans University Mokdong Hospital · Otorhinolaryngology

두경부 종양(두경부·갑상선 종양클리닉), 음성장애(목소리이상), 구강작열감크리닉

5.0
Ajou University Hospital Kim Hye-jin

Kim Hye-jin

Ajou University Hospital · Endocrinology and Metabolism

당뇨병(1형·2형·임신성), 당뇨전단계, 대사증후군, 이상지질혈증, 비만, 갑상선 항진증, 갑상선 저하증, 갑상선 결절

5.0
Ajou University Hospital Jeon Ja-yeong

Jeon Ja-yeong

Ajou University Hospital · Endocrinology and Metabolism

당뇨병(1형·2형·임신성), 당뇨전단계, 대사증후군, 이상지질혈증, 비만, 갑상선 항진증, 갑상선 저하증, 갑상선 결절, 부갑상선 질환, 골다공증, 칼슘대사이상, 내분비질환, 부신종양, 부신기능이상, 뇌하수체질환

5.0
Ajou University Hospital Jang Jeon-yeop

Jang Jeon-yeop

Ajou University Hospital · Otorhinolaryngology

두경부종양(구강암·설암·편도암·후두암·인두암·침샘암), 갑상선암, 음성장애, 기관식도질환, 두경부로봇수술

5.0

Disease Description (Causes and Symptoms)

  • Definition summary: Follicular thyroid cancer is a cancer belonging to the differentiated thyroid cancers and is a tumor originating from thyroid follicles (follicular cells). Along with papillary thyroid cancer, it is classified as differentiated thyroid cancer.
  • Pathophysiology summary: Follicular cancer is diagnosed as malignant only when capsular invasion or vascular invasion is confirmed histologically. Whereas papillary cancer tends to metastasize through the lymph nodes, follicular cancer often metastasizes through the bloodstream to the bones, lungs, and other sites, and frequently absorbs radioactive iodine. Abnormalities in the regulation of cell growth and differentiation (genetic and environmental factors) are causes of its development.
  • Main causes (associated factors): History of head and neck radiation exposure, family history, long-term low-iodine diet (regional differences), and other genetic predispositions.
  • Main symptoms: Most cases are asymptomatic in the early stages and are often detected as nodules during health screenings. When symptoms occur, they may include a lump in the neck (nodule), difficulty swallowing, a foreign-body sensation in the throat, difficulty breathing, and voice changes (when the vocal cords are involved).
  • Diagnostic features: Ultrasonography and fine-needle aspiration (FNA) are important for initial diagnosis, but because it is difficult to distinguish benign from malignant follicular lesions based only on cell morphology, postoperative histopathological examination (to confirm capsular and vascular invasion) is necessary for a definitive diagnosis.

Treatment Methods

  • Surgery
    • Depending on the tumor size, extent of invasion, and clinical risk, a partial resection (lobectomy) or total resection (total thyroidectomy) is performed.
    • If lymph node metastasis is suspected, concomitant resection (lymph node dissection) may be performed.
  • Radioactive iodine (RAI) therapy
    • Oral radioactive iodine is administered after surgery to remove residual thyroid tissue or microscopic metastatic lesions. It is often effective because follicular cancer frequently has a high rate of iodine uptake.
    • Before treatment, iodine uptake is increased through a low-iodine diet and elevation of TSH (by stopping thyroid hormones or administering rhTSH). Temporary isolation and precautions are required after treatment for radiation safety.
  • Thyroid hormone medication (levothyroxine)
    • Taken as lifelong replacement therapy after thyroidectomy. It is also used to suppress TSH and reduce the risk of recurrence and growth (the intensity of treatment is adjusted according to risk).
    • Taking it on an empty stomach (in the morning) is recommended; it should be taken with a time interval from calcium, iron supplements, and similar products.
  • Radiation therapy and systemic treatment
    • External beam radiation therapy (for local control) may be considered for locally advanced or metastatic lesions that cannot be controlled with surgery or RAI.
    • Molecular targeted therapies (e.g., tyrosine kinase inhibitors) may be used for extensive metastases or progressive lesions that do not absorb RAI (consultation with a specialist is required).
  • Follow-up and tests
    • Long-term follow-up is conducted using blood thyroglobulin (Tg) and anti-Tg antibodies, thyroid ultrasonography, and, when necessary, whole-body imaging (radioactive iodine whole-body scans, PET/CT, etc.).
  • Precautions, risk of complications, and self-management
    • Surgical complications: Hypoparathyroidism (hypocalcemia), recurrent laryngeal nerve injury (voice changes), bleeding, infection, and others.
    • RAI side effects: Temporary sialadenitis, dry mouth, and, rarely, effects on reproductive function (fertility)—women of childbearing age must avoid pregnancy before and after treatment and consult about pregnancy planning.
    • Medication interactions involving lifelong thyroid hormone use (calcium, iron, antacids, etc.) and the need to follow the dosing schedule carefully.
  • Prognosis
    • Overall, it is considered a cancer with a good prognosis. Although outcomes vary depending on the stage and presence or absence of metastasis, long-term survival rates are high with appropriate surgery and RAI therapy.

Checklist Before an Outpatient Visit (Items to Bring, Records, and Tests)

  • Items/documents to bring
    • A list of all medications currently being taken, including supplements and herbs
    • Previous thyroid ultrasound and FNA (cytology) results, and surgical and pathology records, if available
    • Recent blood test results (TSH, free T4, Tg, anti-Tg antibodies, etc.) and imaging test results (PET/CT, radioactive iodine scans, etc.)
  • Symptom records
    • Changes in the size of the neck lump (when it began and whether it grew rapidly), difficulty swallowing, difficulty breathing, voice changes, and whether pain is present
    • Weight changes, fatigue, heat intolerance, sweating, and other symptoms related to thyroid function
  • Lifestyle and medical history
    • History of head and neck radiation exposure, family history (thyroid cancer and endocrine diseases), pregnancy status (women of childbearing age), smoking, and alcohol use
  • Preparation for tests
    • If radioactive iodine therapy is scheduled: Instructions on following a low-iodine diet, pregnancy testing (women), and confirmation of whether thyroid hormones should be stopped or whether rhTSH is planned
    • Regarding medication use: Patients taking thyroid hormones should be instructed to follow the guidance to “have blood drawn first, then take the medication” when undergoing blood tests.

Examples of General Questions to Ask the Doctor

  • “What is the basis for diagnosing this lesion as malignant (follicular cancer) based on the pathology findings? (For example, whether capsular invasion or vascular invasion is present.)”
  • “In my case, what is the appropriate extent of surgery (lobectomy vs. total thyroidectomy), and why?”
  • “Is radioactive iodine therapy necessary after surgery? What are the expected effects and side effects?”
  • “What target TSH level should be maintained with hormone therapy (levothyroxine)? What are the side effects?”

Examples of Disease-Specific Questions

  • “Was capsular invasion or vascular invasion confirmed in the pathology results? (This information is decisive for determining the extent of surgery and the follow-up plan.)”
  • “What is the schedule for Tg (thyroglobulin) testing and imaging to check for residual tissue or metastasis after surgery? What is the plan if Tg levels rise?”

Patient stories: Follicular thyroid cancer

Talk with other Follicular thyroid cancer patientsAsk people who have been through itWrite

Hospitals that treat Follicular thyroid cancer

University hospitals where the doctors above see patients. Open a hospital to see its doctors by specialty and how to book.

Find top doctors for 'Follicular thyroid cancer'

Reviewed by · GoodDoctorNet medical specialists

This information is for general understanding only and does not replace diagnosis, prescription or treatment for an individual patient. If you have symptoms, please see a doctor.

Our medical content policy (in Korean) →